PharmaCielo Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. PharmaCielo Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 71% to $1,541,749. Profit margin reached -1057%. Total operating expenses were $8,332,103.

Profit Margin

PharmaCielo Ltd. (TSX:PCLO.V): Profit margin
2017 0 -15.98K
2018 0 -144.39K
2019 786.90K -34.62M -4399.85%
2020 2.65M -44.26M -1667.73%
2021 1.94M -26.91M -1383.94%
2022 5.30M -16.03M -302.11%
2023 1.54M -16.29M -1057.09%

PCLO.V Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
1.54M5.30M1.94M2.65M786.90K00
Cost of revenue
2.91M4.48M6.25M9.45M2.44M00
Gross profit
-1.36M827.05K-4.30M-6.79M-1.65M00
Operating exp.
Research and development
0000000
Selling and marketing
411.95K779.19K1.07M1.12M900.65K00
Total operating expenses
8.33M12.26M20.88M36.61M32.67M118.60K15.98K
Operating income
-9.70M-11.45M-25.46M-43.12M-33.96M-118.60K-15.98K
Other income (expenses), net
-6.59M-3.05M-1.16M-3.38M-703.86K-25.79K0
Income before tax
-16.29M-14.51M-26.62M-43.75M-34.66M-144.39K-15.98K
Income tax expense
01.52M287.99K504.41K-44.88K25.79K0
Net income
-16.29M-16.03M-26.91M-44.26M-34.62M-144.39K-15.98K
Earnings per share
Basic EPS
-0.1-0.11-0.18-0.39-0.36-1.18-0.04
Diluted EPS
-0.1-0.11-0.18-0.39-0.36-1.18-0.04